Langton David, Gaffney Nicole, Wang Wei Chin, Thien Frank, Plummer Virginia
Department of Thoracic Medicine, Frankston Hospital, Peninsula Health, Frankston, Melbourne, VIC, Australia,
Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia,
J Asthma Allergy. 2018 Oct 15;11:261-266. doi: 10.2147/JAA.S179359. eCollection 2018.
A significant correlation has been previously demonstrated between the quantum of radiofrequency treatment delivered at bronchial thermoplasty and the degree of improvement in an asthmatic patient's symptoms. The standard bronchoscope used for bronchial thermoplasty has an outer diameter of 4.8 mm at the distal tip. Thinner bronchoscopes are now available with the same internal channel size (2.0 mm). This study assesses whether using a thinner bronchoscope facilitates bronchial thermoplasty by increasing the radiofrequency activations delivered.
This was a sequential study in a single center, conducted in 27 patients with very severe asthma. The first 12 patients (Group 1) underwent bronchial thermoplasty using the standard bronchoscope, Olympus BF-Q190. In the next group of eight patients (Group 2), the standard bronchoscope was used for all procedures except the left upper lobe, while the left upper lobe was treated with a smaller bronchoscope, Olympus BF-P190, with an outer diameter of 4.2 mm. In the last group of seven patients (Group 3), the smaller bronchoscope was used for every lobe. The quantum of radiofrequency treatment was measured by activations delivered to each lung lobe in each patient, and patient groups were compared by ANOVA.
In this group of 27 patients, the mean age was 56.5±12.9 years, the mean Asthma Control Questionnaire-5 item version score was 3.2±1.0 and the mean FEV% predicted was 55.2±15.7. Bronchial thermoplasty treatment resulted in significant improvements in predicted Asthma Control Questionnaire-5 item version score (to 1.8±1.3, <0.005), salbutamol rescue usage and oral corticosteroid requiring exacerbations, with no significant change in lung function. Use of the smaller bronchoscope resulted in greater radiofrequency treatment (total activations Group 1: 155±21, Group 2: 176±46, Group 3: 213±37; <0.01). There were no significant differences in efficacy or safety outcomes among groups.
Using a thinner bronchoscope facilitates access to the bronchial tree and increases the radiofrequency treatment delivered at bronchial thermoplasty.
先前已证实,支气管热成形术中射频治疗的剂量与哮喘患者症状的改善程度之间存在显著相关性。用于支气管热成形术的标准支气管镜远端外径为4.8毫米。现在有内径相同(2.0毫米)但外径更细的支气管镜可供使用。本研究评估使用更细的支气管镜是否能通过增加射频激活次数来促进支气管热成形术。
这是一项在单一中心进行的序贯研究,纳入了27例重度哮喘患者。前12例患者(第1组)使用标准支气管镜Olympus BF-Q190进行支气管热成形术。在接下来的8例患者(第2组)中,除左上叶外的所有操作均使用标准支气管镜,而左上叶则使用外径为4.2毫米的较小支气管镜Olympus BF-P190进行治疗。在最后一组7例患者(第3组)中,每个肺叶均使用较小的支气管镜。通过测量每位患者每个肺叶的射频激活次数来确定射频治疗剂量,并通过方差分析对患者组进行比较。
在这27例患者中,平均年龄为56.5±12.9岁,哮喘控制问卷5项版本的平均得分是3.2±1.0,预计FEV%平均为55.2±15.7。支气管热成形术治疗使哮喘控制问卷5项版本的预计得分显著改善(降至1.8±1.3,<0.005),沙丁胺醇急救使用量以及需要口服糖皮质激素治疗的急性加重次数均显著减少,肺功能无显著变化。使用较小的支气管镜可进行更多的射频治疗(第1组总激活次数:155±21,第2组:176±46,第3组:213±37;<0.01)。各组之间在疗效或安全性结果方面无显著差异。
使用更细的支气管镜便于进入支气管树,并增加了支气管热成形术中的射频治疗量。